PA
DFTX

Profund Advisors’s Definium Therapeutics DFTX Stock Holding History

Profund Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Sell
13,571
-625
-4% -$15.4K 0.02% 468
2026
Q1 		$268K Sell
14,196
-7,793
-35% -$132K 0.01% 824
2025
Q4 		$294K Buy
21,989
+3,323
+18% +$41.1K 0.01% 887
2025
Q3 		$220K Buy
18,666
+4,959
+36% +$46.2K 0.01% 924
2025
Q2 		$89K Sell
13,707
-3,802
-22% -$25K ﹤0.01% 973
2025
Q1 		$102K Buy
17,509
+5,216
+42% +$37.4K ﹤0.01% 952
2024
Q4 		$85.6K Sell
12,293
-8,550
-41% -$58.8K ﹤0.01% 1081
2024
Q3 		$119K Sell
20,843
-3
-0% -$21 ﹤0.01% 1097
2024
Q2 		$150K Buy
+20,846
New +$182K 0.01% 1019
2022
Q1 		– Sell
-785
Closed -$16K – 1388
2021
Q4 		$16K Buy
785
+106
+16% +$3.38K ﹤0.01% 1372
2021
Q3 		$24K Buy
+679
New +$29.4K ﹤0.01% 1349

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Profund Advisors's DFTX Position: Q2 2026 in Review

Profund Advisors reduced its Definium Therapeutics (DFTX) stake by 4.4% in Q2 2026, selling an estimated $15.4K and leaving 13,571 shares worth $638K. The position accounts for 0.02% of the portfolio, ranked #468.

Profund Advisors first reported a position in DFTX in Q3 2021 and has held it in 11 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Profund Advisors held 13,571 shares of Definium Therapeutics worth $638K as of Q2 2026.
  • Profund Advisors sold 625 Definium Therapeutics shares in Q2 2026, an estimated $15.4K.
  • Definium Therapeutics made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #468 holding.
  • Profund Advisors first reported a position in Definium Therapeutics in Q3 2021 and has held it in 11 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.